DIDACTIC
Acquired by
UI INVESTISSEMENT
DIDACTIC acquired by UI INVESTISSEMENT
Target
DIDACTIC
Acquirer
UI INVESTISSEMENT
Context
Didactic reorganized its shareholder base to accelerate its transformation into a European industrial leader. GENEO Capital Entrepreneur and UI Investissement acquired a majority stake, taking over from the previous sponsor. The transaction involves significant reinvestment from the President and his management team, alongside Bpifrance and MACSF.
This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.4x since the beginning of 2026, 1.2% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded in 1967, Didactic is a leading French player in the design, manufacture, and distribution of medical devices, specifically dedicated to infectious risk management and perfusion. As the market leader in examination gloves and the number two player in medical hygiene in France, Didactic supplies over 4,000 clients, primarily public hospitals and private clinics.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with DIDACTIC
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.